EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours

Author:

Gear JonathanORCID, ,Chiesa Carlo,Lassmann Michael,Gabiña Pablo Mínguez,Tran-Gia Johannes,Stokke Caroline,Flux Glenn

Abstract

AbstractThe purpose of the EANM Dosimetry Committee Series on “Standard Operational Procedures for Dosimetry” (SOP) is to provide advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This SOP describes image and data acquisition parameters and dosimetry calculations to determine the absorbed doses delivered to whole-body, tumour and normal organs following a therapeutic administration of 131I mIBG for the treatment of neuroblastoma or adult neuroendocrine tumours. Recommendations are based on evidence in recent literature where available and on expert opinion within the community. This SOP is intended to promote standardisation of practice within the community and as such is based on the facilities and expertise that should be available to any centre able to perform specialised treatments with radiopharmaceuticals and patient-specific dosimetry. A clinical example is given to demonstrate the application of the absorbed dose calculations.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Instrumentation,Biomedical Engineering,Radiation

Reference61 articles.

1. Giammarile F, et al. EANM procedure guidelines for I-131-meta-iodobenzylguanidine (I-131-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008;35(5):1039–47.

2. Sisson JC, et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med. 1984;25(2):197–206.

3. Chiesa C, et al. Dosimetry in I-131-MIBG therapy: moving toward personalized medicine. Q J Nucl Med Mol Imaging. 2013;57(2):161–70.

4. Buckley SE, et al. Whole-body dosimetry for individualized treatment planning of I-131-MIBG radionuclide therapy for neuroblastoma. J Nucl Med. 2009;50(9):1518–24.

5. Matthay KK, et al. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with I-131-MIBG. J Nucl Med. 2001;42(11):1713–21.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3